Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model
Aim: Experimental and clinical studies showed that the administration of cyclophosphamide (Cy) in low doses leads to an enhancement of the antitumor immune response. Our objective was to study the modulation, if any, by low dose Cy, of T regulatory (Treg) and natural killer T (NKT) I cells, two cell...
Guardado en:
| Autores principales: | Rico, María José, Rozados, Viviana R., Mainetti, Leandro Ernesto, Zacarías Fluck, Mariano, Matar, Pablo, Scharovsky, O. Graciela |
|---|---|
| Formato: | article artículo publishedVersion |
| Lenguaje: | Inglés |
| Publicado: |
MORION LLC
2012
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/2133/2006 http://hdl.handle.net/2133/2006 |
| Aporte de: |
Ejemplares similares
-
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity
por: Rozados, Viviana R., et al.
Publicado: (2012) -
The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
por: Rozados, Viviana R., et al.
Publicado: (2012) -
Modulation of IL-10/IL-10R expression by mafosfamide, a derivative of 4-hydroxycyclophosphamide, in a rat B-cell lymphoma
por: Rico, María José, et al.
Publicado: (2013) -
The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
por: Zacarías Fluck, M.F., et al. -
The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
por: Salatino, Mariana, et al.
Publicado: (2012)